Figure S1. Broad-spectrum antibiotics disrupt microbiota with selection of Enterobacteriaceae. Figure S2. Vancomycin and colistin have different effects on DSS-induced colitis. Figure S3. Effects of antibiotics and DSS treatment on fungal microbiota. Figure S4. Gram-positive bacteria are necessary to trigger DSS-induced colitis. (DOCX 1685 kb
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Table S1. Colistin minimum inhibitory concentrations (MIC) as determined by Vitek and Etest for 100 ...
Current evidence to support extensive use of probiotics in inflammatory bowel disease is limited and...
International audienceBackgroundHost-microbe balance maintains intestinal homeostasis and strongly i...
<p>Background: The aim of this study was to clarify the effect of 5-aminosalicylic acid (5-ASA) trea...
ObjectiveSignificant differences have been discovered between subtypes of Crohn’s disease (CD) and u...
Figure S1. Analysis of relative abundance of PolyFermS commensal bacteria phyla. Relative abundance ...
Heatmap of the 30 OTUs most impacted by antibiotic treatment for each of the 7 patients who did not ...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Linear regression of dysbiosis index versus phylogenetic diversity in patients with CDI with and wit...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Quantitative measurements of E. coli presence in the samples (quantitative culture, qPCR, 16S rRNA g...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Figure S2. Analysis of relative abundance of PolyFermS commensal bacteria genera. Relative abundance...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Table S1. Colistin minimum inhibitory concentrations (MIC) as determined by Vitek and Etest for 100 ...
Current evidence to support extensive use of probiotics in inflammatory bowel disease is limited and...
International audienceBackgroundHost-microbe balance maintains intestinal homeostasis and strongly i...
<p>Background: The aim of this study was to clarify the effect of 5-aminosalicylic acid (5-ASA) trea...
ObjectiveSignificant differences have been discovered between subtypes of Crohn’s disease (CD) and u...
Figure S1. Analysis of relative abundance of PolyFermS commensal bacteria phyla. Relative abundance ...
Heatmap of the 30 OTUs most impacted by antibiotic treatment for each of the 7 patients who did not ...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Linear regression of dysbiosis index versus phylogenetic diversity in patients with CDI with and wit...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Quantitative measurements of E. coli presence in the samples (quantitative culture, qPCR, 16S rRNA g...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Figure S2. Analysis of relative abundance of PolyFermS commensal bacteria genera. Relative abundance...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
BackgroundClostridium difficile infection (CDI) is common in patients with inflammatory bowel diseas...
Table S1. Colistin minimum inhibitory concentrations (MIC) as determined by Vitek and Etest for 100 ...